[Synovial sarcoma. A study of a series of 46 cases]
- PMID: 1318562
[Synovial sarcoma. A study of a series of 46 cases]
Abstract
Synovial sarcoma is a rare malignant soft tissue tumor. The histological diagnosis remains sometimes difficult. The authors report 46 cases, treated in different hospitals in Paris. The medium survival rate of this group (which includes cases treated long ago) is of 30 per cent at 5 years. But only 24 per cent are disease free at this time. At the last follow up, the patients deceased after the fifth year included, the survival rate drops down to 12 per cent. Local recurrences and metastasis are analysed with reference to the different treatments applied. It seems that the association of polychimiotherapy and wide surgical excision might increase the survival rate, but this has to be confirmed in future. Radiotherapy is still a valuable treatment when excision is only limited, or when excision is impossible, due to localisation or extension of the tumor.
Similar articles
-
Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.Acta Orthop Scand Suppl. 2001 Feb;72(300):1-31. Acta Orthop Scand Suppl. 2001. PMID: 11381580
-
Evaluation of clinical outcomes and prognostic factors for synovial sarcoma arising from the extremities.Med Sci Monit. 2008 Jun;14(6):CR305-310. Med Sci Monit. 2008. PMID: 18509273
-
Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.Acta Orthop Scand Suppl. 1994 Jun;259:1-31. Acta Orthop Scand Suppl. 1994. PMID: 8042499
-
Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies.Pediatr Blood Cancer. 2006 Jan;46(1):11-7. doi: 10.1002/pbc.20502. Pediatr Blood Cancer. 2006. PMID: 16292743 Review.
-
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.Clin Endocrinol (Oxf). 2005 Apr;62(4):397-409. doi: 10.1111/j.1365-2265.2005.02231.x. Clin Endocrinol (Oxf). 2005. PMID: 15807869 Review.